KRSA

Korsana Biosciences, Inc. Common Stock

30.14

USD

-0.08

-0.26%

Oct 30, 14:59 UTC -5

Closed

After-Market

30.09

-0.05

-0.17%

Korsana Biosciences, Inc. Common Stock (KRSA) Profile

Korsana Biosciences, Inc. Common Stock Profile

About

Korsana Biosciences Inc. is a biotechnology company discovering and developing novel therapies to reduce the burden of neurodegenerative diseases. Its lead program includes KRSA-028 is a next-generation shuttled antibody targeting amyloid beta for the treatment of Alzheimer's disease. Korsana Biosciences Inc. is based in WALTHAM, Mass.

Info & Links

CEO

Regina Graul

Headquarters

245 FIRST STREET,18TH FLOOR
CAMBRIDGE, MA 02142, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

Korsana Biosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

1.37B

Enterprise Value

1.37B

Enterprise Value/EBITDA(ttm)

-200.61

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

661.82

Price to Book(mrq)

3.96

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

Profit Margin(ttm)

-47.37%

Return on Equity(ttm)

-87.96%

Return on Invested Capital(ttm)

-100.31%

Return on Assets(ttm)

-74.86%

Income Statement

Revenue(ttm)

1.90M

Revenue Per Share(ttm)

2.84

Gross Profit(ttm)

1.90M

EBITDA(ttm)³

-6.82M

Net Income Available to Common(ttm)

-6.71M

Diluted EPS(ttm)

-11.62

Share Statistics

Beta (5Y Monthly)

1.72

52-Week Change

S&P 500 52-Week Change

17.54%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

668.97K

Dividend Yield

0.00%

Float⁴

31.41M

% Held by Insiders

31.04%

% Held by Institutions

75.62%

Balance Sheet

Total Cash(mrq)

1.39M

Total Cash Per Share(mrq)

2.08

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.82%

Quick Ratio(mrq)

0.82%

Book Value Per Share(mrq)

8.36

Cash Flow

Operating Cash Flow Per Share(ytd)

-4.29

Free Cash Flow(ytd)

-2.67M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.